SCHEMBL6028398

SCHEMBL6028398

COc1ccc2[nH]cc(CCN3C(=O)C(C(C)C)Oc4c(OC)cc(Br)cc4C3C(=O)Nc3c(C)cccc3C)c2c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 9/20 0.41
POLB P06746 1/20 0.40
ABCB1 P08183 1/20 0.40
ABCC1 P33527 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
HCRTR2 O43614 4/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HCRTR1 O43613 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556324 0.91 MEN1 (0.46) ABCG2ABCB1ABCC1MAPTBCHE
SCHEMBL5556164 0.88 ALDH1A1 (0.41) ABCG2POLBABCB1ABCC1ALDH1A1
SCHEMBL5561157 0.88 RAB9A (0.44) ABCG2POLBABCB1ABCC1ALDH1A1
SCHEMBL5556320 0.86 LMNA (0.44) ABCG2ALDH1A1MAPTL3MBTL1NPC1
SCHEMBL5562035 0.81 ALDH1A1 (0.42) ALDH1A1MAPTNPC1RAB9AMEN1
SCHEMBL5562108 0.80 MEN1 (0.48) ABCG2MAPTHCRTR2NPC1RAB9A
SCHEMBL5556348 0.78 MTNR1A (0.41) ABCG2ABCB1ABCC1ALDH1A1MAPT
SCHEMBL5561282 0.77 MEN1 (0.50) ALDH1A1MAPTL3MBTL1BCHEACHE
SCHEMBL5562105 0.77 LMNA (0.44) ABCG2ALDH1A1MAPTL3MBTL1MTNR1A
SCHEMBL5561897 0.75 MEN1 (0.47) MAPTBCHEACHEHCRTR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631296-A1 2,3,4,5-TETRAHYDROBENZO[F][1,4]OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 EP disclosed
WO-2004100958-A1 2, 3, 4, 5-TETRAHYDROBENZO[F][1, 4]OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 WO disclosed